The HealthRX.com clinical team uses a four-criteria framework to determine which patients are most likely to benefit from pramlintide: (1) A1C driven primarily by postprandial excursions rather than fasting hyperglycemia, (2) body weight above goal with patient preference to avoid weight-gaining agents, (3) gastroparesis absent on clinical screening, and (4) willingness to use a separate injection device and reduce mealtime insulin proactively
2021;doi:10.1001/jamacardio.2021.5083 Shapiro MD, Fazio S
Heal and Reset Your Mind & Body What are the benefits of DSIP
Contact ChoicePoint today for a dual diagnosis and begin your recovery journey 844.445.2565
Most users come from wealthier households, and mostly households with children
NF1 is characterized by multiple benign neurofibromas, caf-au-lait spots, and an increased lifetime risk (approximately 813%) of developing MPNST (Evans et al., 2021)